Our Partner (Head – Pharma & Healthcare) Ashwin Sapra in an article published by The Economic Times shares his views on the impact of 25% U.S. tariffs on Indian pharma exports, which could raise costs, hurt profits, and cause U.S. drug shortages. (Photo Credit: The Economic Times)
